Oncotherapy Solutions
Company Details
Status: Private
Employees: 1-10
Location:
Seattle, Washington, United States
Type:
sample
Technology:
sample
sample
About: Oncotherapy Solutions LLC currently has three preclinical programs and a lead drug conjugate for ovarian cancer and triple-negative breast cancer. The lead drug conjugate is also expected to be effective on cancers of the colon, pancreas, lung and brain. The second research program is on the development of new multi-kinase inhibitors for the treatment of a variety of hematological and solid tumors. This program is in early proof of concept preclinical phase. The third research program is on the development of novel vaccines and checkpoint inhibitors to activate the patient's own immune cells to recognize and destroy cancer cells. This program is on hold until appropriate funds are secured.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Oncotherapy Solutions | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.